FF

Flagg Flanagan

Chief Executive Officer & Chairman of the Board

DiscGenics

Salt Lake City, Utah


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
DiscGenics
Industry
research
Employees
37.0
Seniority
C suite
Annual Revenue
15972000.0
Total Funding
68000000.0
Latest Funding
Series C

Technologies

Outlook Ubuntu Shutterstock YouTube Google Tag Manager Mobile Friendly Google Analytics Nginx Typekit Remote

Keywords

biotechnology research degenerative disc disease cell therapy regenerative medicine injectable therapy low back pain clinical trials discogenic cells idct progenitor cells spinal health pain management fda approval non-surgical treatment biologics therapeutic solutions chronic pain patient care intervertebral disc regenerative therapies bioengineering surgical alternatives medical innovation clinical evaluations spinal disorders pain alleviation tissue regeneration cell-based therapy fda designation patient outcomes musculoskeletal health scientific research biopharmaceutical development regulatory compliance systematic reviews research collaboration quality management system integrity medical device technology treatment efficacy healthcare solutions rehabilitation strategies healthcare funding risk management biotech partnerships market research therapeutic interventions health technology assessment health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans